FBXO32 and muscle atrophy: Muscle atrophy, a significant complication associated with diabetes, is characterized by reduced muscle protein synthesis and increased protein degradation, partly mediated by activation of the ubiquitin protease system with elevated E3 ubiquitin ligases atrogin-1 (MAFbx) and MuRF1 [24].